- Home
- BNTC vs ZVRA Comparison
BNTC vs ZVRA Comparison
Compare BNTC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTC | ZVRA |
|---|---|---|
| Founded | 1995 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.4M | 472.9M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BNTC | ZVRA |
|---|---|---|
| Price | $12.50 | $11.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $27.67 | $23.00 |
| AVG Volume (30 Days) | 97.6K | ★ 739.7K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.94 | ★ 159.21 |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $106,470,000.00 |
| Revenue This Year | N/A | $37.27 |
| Revenue Next Year | N/A | $53.42 |
| P/E Ratio | ★ N/A | $7.90 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $9.85 | $7.16 |
| 52 Week High | $17.15 | $13.16 |
Technical Indicators
Market Signals| Indicator | BNTC | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 66.68 |
| Support Level | $11.39 | $8.30 |
| Resistance Level | $13.27 | $12.14 |
| Average True Range (ATR) | 0.65 | 0.44 |
| MACD | -0.10 | 0.05 |
| Stochastic Oscillator | 38.70 | 98.88 |
Price Performance
Historical ComparisonAbout BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.